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Glaucoma after corneal transplantation is a leading cause of ocular morbidity after penetrating keratoplasty. The incidence
reported is highly variable and a number of etiologic factors have been identiﬁed. A number of treatment options are available;
surgical intervention for IOP control is associated with a high incidence of graft failure. IOP elevation is less frequently seen
following deep anterior lamellar keratoplasty. Descemet’s striping-automated endothelial keratoplasty is also associated with
postprocedure intraocular pressure elevation and secondary glaucoma and presents unique surgical challenges in patients with
preexisting glaucoma surgeries. Glaucoma exists in up to three-quarters of patients who undergo keratoprosthesis surgery and
the management if often challenging. The aim of this paper is to highlight the incidence, etiology, and management of glaucoma
following diﬀerent corneal transplant procedures. It also focuses on the challenges in the diagnosis of glaucoma and intraocular
pressure monitoring in this group of patients.
1.Introduction
The primary goal after corneal transplantation is reestab-
lishment of visual acuity for the patient. Corneal transplant
surgery has evolved markedly in the past decades from a
process of simple replacement of the whole corneal thickness
as in penetrating keratoplasty to include deep lamellar ker-
atoplasty (DALK), Descemet’s striping-automated endothe-
lial keratoplasty (DSAEK), and keratoprosthesis (KPro).
Achieving good visual acuity requires a clear graft and low
and regular corneal astigmatism but could be limited by
glaucoma and retinal pathology. Unfortunately, the onset
and/or progression of glaucoma in patients undergoing
transplantation remains a challenge with diﬃculties faced
in the diagnosis and management of these patients. The
aim of this paper is to highlight the incidence, etiology,
and management of glaucoma following diﬀerent corneal
transplant procedures. It also focuses on the complexity on
diagnosing glaucoma and monitoring intraocular pressure
in this group of patients. A brief overview over procedures
thataltersthecorneaincludingcornealrefractivesurgeryand
corneal collagen crosslinking (CXL) is also included.
2.Glaucoma andPenetratingKeratoplasty
Glaucoma is a serious complication after PKP because of
its high incidence and severity and the challenges associated
with its diagnosis and treatment [1]. Postkeratoplasty glau-
comarepresentsthesecondleadingcauseofgraftfailureafter
graft rejection [2–5].
2.1. Incidence of Glaucoma Following PKP. An u m b e ro f
studieshavereportedontheincidenceofglaucomafollowing
PKP. Franc ¸a et al. [6] studied incidence of glaucoma in 228
patients who underwent PKP. Forty-nine patients (21.5%)
developed glaucoma. In another study by Karadag et al. [7]
that included 749 eyes in 729 patients, which underwent
PKP, intraocular pressure (IOP) increased in the early
postoperative period in 41 (5.5%) eyes and chronically
elevated IOP was reported in 124 (16.6%) eyes. The average
period between surgery and the ﬁrst IOP elevation was
5.0 ± 6.5 months for all eyes. The mean IOP value of eyes
that developed glaucoma after PKP was 27.9 ± 5.8mmHg.
Al-Mohaimeed et al. [8] studied prevalence for escalation
of glaucoma therapy after PKP in 715 consecutive eyes of2 Journal of Ophthalmology
678 patients that underwent PKP. Escalation of glaucoma
therapy occurred in 89 (12.4%) eyes of 715 PKP procedures
during a mean followup of 32.2 months, out of which 29
eyes had preexisting glaucoma. Wagoner et al. [9]r e p o r t e d
worsening of preexisting glaucoma in 15.5% of 66 adult
patients who underwent primary optical PKP. Studies by
Goldberg et al. [10], Kirkness and Ficker [11], Polack [12],
and Simmons et al. [13] also reported a low incidence
of secondary open-angle ocular hypertension after PKP in
k e r a t o c o n u sa n dF u c h s ’d y s t r o p h y .T h er a t eo fg l a u c o m a
occurrence in keratoconus and Fuchs’ dystrophy was similar.
In summary of the literature, the incidence of secondary
glaucoma after PKP is highly variable, ranging from 10% to
42%thatdependedonthesurgicalindicationofPKPandthe
complexity of surgery [10–17].
2.2. Etiology and Risk Factors of Glaucoma Following PKP.
The pathophysiology of post-PKP glaucoma is multifactorial
and may be related to distortion of the angle with collapse of
the trabecular meshwork, suturing technique, postoperative
inﬂammation, use of corticosteroids, peripheral anterior
synechiae (PAS) formation, and preexisting glaucoma [18].
O l s o na n dK a u f m a n[ 19], using a mathematical model,
proposed that the elevated IOP following PKP in an aphakic
patient might be the result of angle distortion secondary to
a compressed tissue in the angle. Edema and inﬂammation
after surgery lead to further compromise in the trabecular
meshwork function, and the situation is further aggravated
by angle distortion. Factors that contribute to angle distor-
tion include tight suturing, long bites, larger trephine sizes,
smaller recipient corneal diameter, and increased peripheral
corneal thickness.
Zimmermanetal.[20]proposedthatthemechanicalcol-
lapse of the trabecular meshwork in aphakic grafts was the
main problem leading to glaucoma. They postulated that the
trabeculum needs posterior ﬁxation oﬀered by the ciliary
body-lens support system and an anterior support oﬀered by
the descemet’s membrane. In aphakia, the posterior support
is relaxed with the removal of the lens. After PKP, Descemet’s
membrane is incised, which leads to a relaxation of the ante-
rior support. Both these factors lead to a partial trabecular
collapse and obstruction of aqueous outﬂow. It would be
interesting to evaluate some of these hypothesis related to
trabecular alteration as a cause of glaucoma following PKP
using newer anterior segment imaging techniques that can
visualize the trabecular outﬂow pathways.
Retained viscoelastic material is another important cause
forincreasedIOPintheearlypostoperativeperiod,especially
with the use of cohesive viscoelastics and its combination
with chondroitin sulfate used during PKP.
The leading cause for late post-PKP glaucoma, however,
is synechial angle closure with the degree of synechial closure
strongly correlated with the need for glaucoma surgery [21].
A ﬂoppy atrophic iris may also lead to a higher incidence of
PAS formation, which can be prevented by iris suturing or
iridoplasty [22].
The incidence of postoperative IOP elevation is associ-
ated with surgical indication. The lowest incidence of IOP
rise was reported in the patients with keratoconus [10, 13,
14]. Bullous keratopathy, graft rejection, history of glau-
coma, and trauma were reported to be high-risk factors for
IOP elevation following PKP [11–13]. Wagoner et al. [9]
reported that eyes with corneal edema were more likely to
develop than those with stromal scaring (P<0.001).
Preoperative glaucoma was identiﬁed as a major risk
factor for post-PKP glaucoma in many studies [3, 5, 10, 14,
15]. Karadag et al. [7] included 32 patients with preoperative
glaucoma who had medical or surgical treatment before
surgery. The incidence of post-PKP glaucoma was 59.4%
in eyes with preexisting glaucoma in contrast to 14.6% in
cases without such a history (P = 0.0001). Also, the control
of IOP signiﬁcantly worsened in cases with preoperative
glaucoma. The preoperative diagnoses of the patients who
developed glaucoma was graft rejection in 27 (21.7%)
patients, pseudophakic bullous keratopathy in 24 (19.3%)
patients, aphakic bullous keratopathy in 14 (11.2%) patients,
corneal scar in 14 (11.2%) patients, vascularized scar in nine
(7.2%) patients, trauma in ﬁve (4%) patients, keratoconus in
nine(7.2%)patients,cornealdystrophyinﬁve(4%)patients,
corneal abscess in four (3.2%) patients, graft thinning in
four (3.2%) patients, graft abscess in three (2.4%) patients,
scar formation secondary to herpetic keratitis in two (1.6%)
patients, and band keratopathy in one (0.8%) patient.
PAS formation preoperatively or as a consequence of
a preceding intraocular surgery was signiﬁcantly associated
withthedevelopmentofpostoperativeglaucoma[11,13,23].
Some studies found that aphakic and pseudophakic eyes
in the presence of PAS had a greater tendency to develop
post PKP glaucoma when compared with phakic eyes [12–
14]. Other studies found no diﬀerence between aphakic and
pseudophakic eyes but reported a higher incidence of post-
PKP glaucoma in pseudophakic and aphakic eyes compared
with phakic [7].
Some authors reported an increased in the relative risk
associated with post-PKP glaucoma following combined
surgicalprocedurewithPKP[11,13].Seitzetal.[24]assessed
the impact of the trephination method and simultaneous
cataract surgery on the early and long-term IOP after PKP
in eyes without previous surgery and glaucoma in patients
with keratoconus and Fuchs’ dystrophy. An IOP> 21mmHg
and/or application of topical antiglaucoma medication was
documented in 9% of patients where excimer laser-assisted
trephination was performed versus 15% of control patients
that underwent traditional trephination of the corneal
button (P = 0.32), in 15% of Fuchs’ dystrophy versus 11% of
keratoconus cases (P = 0.41) and in 11% of PKP only versus
15% of triple-procedure cases (P = 0.68). The IOP elevation
started an average of 3.7 ± 2.8 months (1 week to 9 months)
after PKP. They concluded that there was no detectable
impact from the trephination method, the diagnosis, or
simultaneous cataract surgery. This was supported by other
studies that did not report a statistically signiﬁcant diﬀerence
in IOP following PKP between patients who underwent a
combined procedure and those who did not [6, 14].
The presence of ocular inﬂammation before in the pre-
or postoperative period is an important risk factor for post-
PKP glaucoma [6, 18, 25].Journal of Ophthalmology 3
Prolonged use of topical steroids after PKP makes these
patients more vulnerable to complications including IOP
elevation.Steroid-inducedIOPelevationisoneoftheimpor-
tant causes of late-onset postkeratoplasty glaucoma [26].
Pramanik et al. [27] reported steroid-induced glaucoma in
4 (3.6%) of 112 eyes of patients with keratoconus after PKP
with a mean followup of 13.8 years. Erdurmus et al. [28]
evaluated the frequency of steroid-induced IOP elevation
and/or glaucoma in patients with keratoconus compared
with patients with Fuchs’ endothelial dystrophy after PKP.
A total of 100 patients with keratoconus and 58 patients
withFuchsdystrophywereincludedinthisstudy.Theoverall
frequency of steroid-induced IOP elevation after PKP was
73% in the keratoconus group and 60.3% in the Fuchs
dystrophy group. The frequency of IOP elevation of at least
5 or 10mmHg over the preoperative baseline was 72%
and 24% in keratoconus group and 56.9% and 20.7% in
the Fuchs dystrophy group, respectively. The frequency of
IOP elevation ≥22 or ≥30mmHg was 22% and 6% in
the keratoconus group and 29.3% and 1.7% in the Fuchs
dystrophy group, respectively. Most IOP measurements
were done by Goldmann’s applanation tonometry unless
irregularityofthemiresprecludedaccuratereadings.Inthese
cases and during the ﬁrst week after surgery a Tono-Pen
(Medtronic Solan Mentor, Norwell, MA, USA) was used. No
diﬀerence between the groups in terms of frequency of IOP
elevation was observed (P>0.05 for all). Fan et al. [29]
reported a 53% elevation of IOP in 57 eyes that occurred
mostly 3–6 months following keratoplasty. In summary, IOP
elevation related to steroid use is fairly common and requires
careful monitoring.
Interestingly concomitant glaucoma surgery was found
to be signiﬁcant risk factorfor graft failure, but simultaneous
cataract surgery was not [30].
Knowledgeoftheriskfactorsmayhelponetotakeappro-
priate measures to limit the occurrence of glaucoma follow-
ing PKP and increase the chances of success of the corneal
graft.
2.3. IOP Measurement and Assessment of Glaucoma Damage
Following PKP. FollowingPKP,changesincornealthickness,
postoperative astigmatism, and refractive changes often
preclude reliable postoperative assessment of IOP, disc, and
visual ﬁeld.
IOP in the early postoperative period, when the corneal
surface is irregular, can be measured with the Mackay-Marg
electronicapplanationtonometer[31],thepneumaticappla-
nation tonometer, the Tono-Pen, or the dynamic contour
tonometer (DCT). These instruments appear to measure
IOP independent of the corneal thickness within certain
ranges of IOP [18]. If the corneal graft surface is smooth
with an intact epithelium and regular mires can be obtained,
then Goldmann’s applanation (GAT) can be used to measure
the IOP. The accuracy of applanation tonometry is reduced
in certain situations, such as corneal edema, scars, blood
staining, or any condition that thickens or alters the corneal
elasticity. Corneal epithelial edema and stromal edema
predispose to inaccurately low readings, whereas pressure
measurements taken over a corneal scar will be falsely high
[32]. One of the challenges of measuring or evaluating IOP
preoperatively can be the status of the cornea. The presence
of corneal scarring or edema may make more diﬃcult to
accurately measure IOP in the preoperative period, and the
degree of suture-induced astigmatism following PKP may
also make the measurement of IOP challenging. Studies
reporting IOP changes from baseline in eyes with marked
alterations in the preoperative state must be interpreted
cautiously. The use of a pneumatonometer and frequency-
doubling perimetry were reported as helpful supplemental
methods to detect early glaucomatous damage in patients
after PKP independent of postoperative topographic changes
of the cornea [33].
2.4. Management of Glaucoma Following PKP
2.4.1. Medical Management. The use of topical medications
to control IOP is still the ﬁrst-line treatment of post-PKP
glaucoma. When using topical drugs to lower the IOP, one
has to keep in mind the side eﬀects that are peculiar to them
in the setting of post-PKP glaucoma. Beta-adrenergic block-
ers can lead to superﬁcial punctate keratopathy, exacerbation
of dry eye, and corneal anesthesia. Alpha-2-adrenergic ago-
nistdrugscanleadtoallergicperiocularreactions,superﬁcial
punctatekeratopathy,anddryeyes[34].Theuseofmioticsin
this setting is discouraged, because they promote breakdown
of blood aqueous barrier, thus stimulating graft rejection
and increasing the risk of retinal detachment, particularly
in aphakes. The prolonged use of topical carbonic anhydrase
inhibitors can lead to graft decompensation in the presence
of borderline corneal endothelial status [35]. Finally, the
prostaglandin analogs should also be used with caution as
they may lead to uveitis, cystoid macular edema (CME)
in aphakia and pseudophakia, and reactivation of herpes
simplex keratitis in patients grafted with a previous history
of healed herpetic keratitis [36, 37]. The use of adrenergic
agents like epinephrine, dipivefrin, is also discouraged in the
modern-day management of these patients because of their
potential corneal epithelial toxicity, exacerbation of CME
in aphakes, pseudophakes, and promotion of conjunctival
inﬂammationtherebymakingfuturesurgicalinterventionall
the more diﬃcult [18].
In cases of steroid responsive glaucoma, the dose of ster-
oiddropsmaybetaperedtotheminimumrequired.Alterna-
tively, steroids such as Prednisolone or dexamethasone that
are potent IOP elevating agents can be replaced by steroids
thathaveadecreasedtendencytoincreaseIOPsuchastopical
ﬂuorometholone, loteprednol, and rimexolone. To prevent
graft rejection, Cyclosporine A 0.5–2.0% topical drops four
timesdailycanbeappliedinconjunctionwithweakertopical
steroids to prevent steroid-related ocular hypertension [38].
2.4.2. Surgical Management
Trabeculectomy. Conventional trabeculectomy is usually not
eﬀective due to dense perilimbal scarring resulting in an
increased risk of failure. The failure rate is further increased
in aphakic eyes where a vitrectomy is required to prevent4 Journal of Ophthalmology
vitreous from blocking the trabeculectomy ostium. An-
timetabolites must be used in these patients to inhibit the
ﬁbroblastic response [39]. The reported success rate of IOP
control with mitomycin trabeculectomy in patients with
post-PKPglaucomais67–91% afterameanfollowupof 23±
13 months [40, 41].
Glaucoma Drainage Devices (GDDs). The Use of GDDs Ap-
pears to Control Glaucoma in a High Percentage of Patients
in All Published Series (71–96%, with an Average of 84.8%)
(Figure 1). However, Placement of a GDD Appears to be
Associated with a High Incidence of Graft Failure in the
Range of 10–51% (Average 36.2%) after a Followup of 8
to 74 Months [42–44]. The Risk of Graft Rejection May
be Increased after GDD Surgery, Because the Drainage
Tube May Provide a Conduit for Retrograde Passage of
Inﬂammatory Cells Into the AC. The Risk of Graft Rejection
isSimilarwithValvedorNonvalvedGDD’s[18].TheAuthors
Believe That Implantation of GDDs Behind the Iris May Play
aRoletoReducetheFlowofInﬂammatoryCellsIntoACand
Therefore Reduce the Rate of Endothelial Cell Loss or Graft
Rejection (Figure 4).
Cyclodestructive Procedures. Methods of cyclodestruction
used to control IOP elevation after PKP include cyclocryo-
therapy, Nd:YAG laser cyclophotocoagulation (CPC), diode
laser CPC, transpupillary argon laser photocoagulation, and
endoscopic CPC. Cyclocryotherapy, transscleral CPC with
diode,orkryptonlaserarethevariousproceduresthatcanbe
performed on patients with intractable post-PKP glaucoma.
CPC is a widely adopted procedure, because it is noninvasive
and can be done as a low-cost outpatient procedure [18].
It is especially useful in eyes which develop intractable
elevation of IOP in the early postoperative period after PKP.
In addition it is a useful modality to control IOP in eyes
that have undergone multiple ocular procedures and severe
conjunctival scarring and eyes with poor visual potential.
Insummary,despitethegreatrelation betweenglaucoma
and PKP, the mechanisms appear to be multifactorial.
However,manymechanismsthathavebeenproposedarenot
completely understood. The lack of prospective studies in
thisregardleadstovariationinthereportedrateofglaucoma
following PKP. Prospective studies are required to evaluate
the mechanism and incidence of glaucoma following PKP.
3. Glaucoma and DeepAnterior
LamellarKeratoplasty
The incidence of glaucoma following DALK was reported
to range from zero to 9% after an average followup of
16.0 ± 10.3 months. None of the eyes in the reported series
whichconsistedofasmallnumberofeyesrequiredglaucoma
surgery to control IOP. Escape of air through trabecular
meshwork when performing big bubble technique can lead
to transient elevation of IOP. If air got entrapped behind the
iris, then pupillary block glaucoma can develop. If control
of IOP elevation is required, the management of glaucoma
Figure 1: Glaucoma drainage device (Ahmed tube) combined with
PKP.
following DALK is the same as that following PKP [45, 46]
(Figure 2).
4.Glaucoma andDescemet’s
Striping-Automated
Endothelial Keratoplasty
DSAEK has become a popular technique for the treatment
of corneal endothelial dysfunction. Even after corneal edema
has resolved, the corneal thickness after DSAEK remarkably
increases when compared to a normal cornea, because of
the addition of the thickness of the donor graft. The average
corneal thickness of the cornea following DSAEK is reported
to be 690 ±77μm[ 47].
4.1. Incidence of Glaucoma Following DSAEK. In multi-
ple reports, the incidence of induced glaucoma has been
reported to be from zero to 18% [48–52]. Vajaranant et al.
[53] reported a relatively high incidence of IOP elevation
after DSAEK in 35% of patients with no prior glaucoma,
45% of patients with prior glaucoma, and 43% of patients
with prior glaucoma with preexisting glaucoma surgery. The
overall incidence appears to be lower, less severe, and with
better outcomes than that reported with PKP.
4.2. Etiology of Glaucoma Following DSAEK. In the early
postoperative period, pupillary block from air behind the
pupil may occur. This is an uncommon cause of IOP
elevation but often leads to signiﬁcant complications such
as graft failure and chronic glaucoma [54]. In the later
postoperativeperiod,thedevelopmentofPASandprolonged
steroid use are important causes. Another mechanism of
glaucoma after DSAEK could be distortion of the angle
leading to increased IOP. However, this seems less likely as
the incision is much smaller than that with traditional PKP.
Inﬂammatory glaucoma is also possible but less likely.
4.3. IOP Measurement Following DSAEK. In clinical use,
GAT remains a gold standard for measurement of IOP. It is,
however, calibrated for a mean corneal thickness of 520μm.
The increased corneal thickness in patients with DSAEK,Journal of Ophthalmology 5
Figure 2: Glaucoma drainage device (Ahmed tube) combined with
DALK.
however, does not aﬀect IOP measurements by GAT as
reportedbyVajaranantetal.[55]andothers[56].Additional
dynamic contour tonometry (DCT) and pneumotonometry
which may measure IOP independent of corneal thickness,
curvature, and hydration within certain ranges of IOP may
be useful methods to measure IOP following DSAEK [57–
60].
4.4. Management of Glaucoma Following DSAEK
4.4.1. Medical Management. Vajaranant et al. [55]r e p o r t e d
that glaucoma medications were started during the ﬁrst
year after DSAEK in 18% of patients without preexisting
glaucoma and were increased in 33% of patients with
preexisting glaucoma. Most patients managed well medically
with increase in their glaucoma medications and/or tapering
of steroids or switch to less potent steroids.
4.4.2. Surgical Management. Vajaranant et al. [55]r e p o r t e d
0.3% patients without preexisting glaucoma (1 out of 315)
and 8% patients with preexisting glaucoma (7 out of 85) that
required glaucoma surgery following DSAEK. The risk of
surgical intervention was greater in patients with preexisting
glaucoma or in patients with previous glaucoma surgery.
The options of trabeculectomy, GDDs, or cyclodestructive
procedures are all valid. Usually the approach is similar to
that of PKP. Challenges that might be faced include working
with a slightly shallow anterior chamber that is not uniform
in depth because of edge of graft. Although the optimal
tube location for DSAEK patients is not known, primary
tube insertion into the posterior chamber may become the
preferred option. The tube lumen of a GDD device can
potentially be blocked if it impinges against the thick edge
of the corneal graft. Using a short tube in anterior chamber
placed tangentially into the anterior chamber angle is also
advisable (Figure 3). Graft dislocation is not considered an
issue if GDDs being placed after and not during DSAEK.
DSAEK is a relatively new procedure, and the short-
term incidence of glaucoma and treatment outcomes seem
promising. Studies describing long-term IOP and IOP
treatment-related outcomes will be important in the future.
Figure 3: Glaucoma drainage device (Ahmed tube) combined with
DSAEK (Courtesy of Dr. Jose Morales).
Figure 4: Glaucoma drainage device (Ahmed tube) implanted
behind the iris in a case of DSAEK following pesudophakic bullous
keratopathy (courtesy of Dr. Jose Morales).
5. Glaucoma andKeratoprosthesis
Glaucoma is common and permanent blinding sequel of
KPro surgery. Several types of KPro are in use; Boston KPro
is the most commonly used in the USA, whereas the osteo-
odontokeratoprosthesis is used more frequently elsewhere.
5.1. Incidence of Glaucoma Following KPro. The prevalence
of glaucoma in patients undergoing KPro placement ranges
from 36 to 76%. De novo glaucoma has been reported to
occur in 2–28% of patients after KPro implantation [61–64].
Preexisting glaucoma in eyes that undergo keratoprosthesis
is not uncommon.
5.2. Etiology of Glaucoma Following KPro. As most KPro
recipients have undergone penetrating keratoplasty, some
degree of synechial angle closure usually already exists and
progressiveangleclosureispresumedtobeacausativefactor.
Crowding the anterior segment by the KPro’s large backplate
that is placed in close proximity to the iris can compromise
the angle. Leaving a patient aphakic or removing the iris to
eliminate scaﬀolding can distort and collapse the trabecular
meshwork [59]. Topical medications may also play a role
in the progression of glaucoma in KPro recipients as the6 Journal of Ophthalmology
use of topical steroids for prolonged periods following KPro
implantation can lead to steroid induced glaucoma [65].
5.3. IOP Measurement Following KPro. Placement of the
PMMA optic and the 8.5mm backplate invalidates both
central and peripheral applanation values. Tono-Pen mea-
surements at the limbus may provide a rough assessment
of the IOP (particularly when compared with measurements
from the other eye taken at a corresponding limbal location),
but the readings obtained are highly variable. IOP estimates
using globe palpation is the most commonly employed
method of estimating IOP in patients post-KPro implan-
tation. Digital palpation of the globe should be performed
with the patient gently looking down and the ﬁngers places
above the tarsal plate. Finger tension has been demonstrated
to be fairly accurate at detecting IOPs of 30mmHg or more
particularly when performed by experienced observers [65].
5.4. Management of Glaucoma Following KPro. The manage-
ment of glaucoma following KPro is usually surgical. Some
surgeons consider placing a GDD implant in all patients
undergoing KPro surgery. A meticulous preoperative evalua-
tion of the angles and optic disc, either clinically or with help
of ultrasound, is mandatory in order to assess postoperative
development or progression of glaucoma. GDD implanta-
tion is usually done at the time of KPro surgery in cases with
mild optic nerve damage. Dohlman et al. [66] studied the
connection of the Ahmed shunts to distant epithelialized
cavities(lacrimalsac,ethmoidalsinuses,maxillarysinus,and
the lower lid fornix). The incidence of severe infection was
verylow,infactcomparabletothatafterstandardtrabeculec-
tomy.
Patients with uncontrolled IOP or advanced optic nerve
damage should ideally have glaucoma surgery in the form
of GDD implantation or CPC 3–6 months prior to KPro
surgerytoknowhowmanymedicationswillberequiredafter
KPro surgery.
Only patients with open angles and normal pre-KPro
pressures oﬀ medications, without anticipated manipulation
ofthe lens oriris, shouldproceedtoKPro placementwithout
glaucoma surgical intervention [65].
CPC can be performed at the time of or subsequent to
KPro placement. Success has been reported with both endo-
scopic and transscleral methods [63, 64, 67, 68]. Multiple
applications may be required over time.
6. Glaucoma and Corneal RefractiveSurgery
Though refractive surgery does not strictly qualify as a cor-
neal transplantation, the structure of the cornea is altered
dramatically and deserves brief comment in this paper.
6.1. Etiology of Glaucoma Following Corneal Refractive Sur-
gery. During LASIK surgery, large intraocular spikes can
occur during corneal ﬂap construction, which might acutely
damage the optic nerve or cause retinal vascular occlusions
[69–72].TheIOPspikesmaybelessseverewithfemtosecond
laser-assisted LASIK. In addition, refractive surgery patients
are often moderate-to-high myopic, who may have a higher
predisposition to the development of primary open angle
glaucoma (POAG) [73, 74], pigmentary glaucoma [74, 75],
and steroid-induced glaucoma [76, 77].
6.2. IOP Measurement Following Corneal Refractive Surgery.
ThemeasurementofIOPaftercornealrefractivesurgerymay
not be accurate because of changes in central corneal thick-
ness. Corneal ablative procedures decrease CCT and alter
structural biomechanical properties of the cornea resulting
in spuriously low IOP measurement.
Standard GAT pressures are altered after refractive sur-
gery due to biomechanical changes in cornea [78–81]. No
reliable nomograms to estimate the eﬀects of refractive
surgery on corneal dynamics and IOP exist. Tono-Pen and
pneumotonometry are less aﬀected by refractive surgery
comparedtoGAT[81–84].DCTorOcularresponseanalyzer
(ORA) may provide more reproducible data when compar-
ing postoperative IOP with baseline [85].
7. Glaucoma andCorneal
Collagen Cross-Linkage
Corneal stiﬀening following corneal CXL could potentially
alter corneal biomechanics and the measurement of IOP,
but this eﬀect has not been studied extensively. Kymionis et
al. [86] reported a statistically signiﬁcant increase in GAT
measured IOP 6 months and 12 months after CXL (both P<
0.001). The mean IOP was 9.95mmHg ± 3.01 before CXL,
11.40 ± 2.89mmHg at 6 months, and 11.35 ± 3.38mmHg
at 12 months. This slight change was probably caused by an
increase in corneal rigidity.
8. Conclusion
Glaucoma is a well-established complication following cor-
neal transplant procedures. In addition, corneal surgeries
that either increase or decrease the corneal thickness repre-
sent a challenge for IOP measurement and establishment of
a diagnosis of glaucoma. It is mandatory that the intraocular
pressure should be monitored on a regular basis after corneal
transplantation procedures and aggressively treated if found
to be high. Any patient with preexisting glaucoma must
be carefully evaluated prior to the corneal transplants. It is
equally important, when possible, to obtain other tests such
as visual ﬁeld testing and optic disc imaging to monitor
progression of glaucoma. The lack of prospective studies
adds to the diﬃculty of determining the true incidence, risk
factors, and standard protocols for management. Multicen-
tre, prospective studies may help establish better protocols
for followup and management of patients with elevated
IOP following corneal procedures to avoid the devastating
outcomes of glaucoma.
FinancialDisclosure
The authors have no proprietary or commercial interest in
any material discussed in this article. No ﬁnancial supportJournal of Ophthalmology 7
was received. This case was registered and approved by the
ethical committee in King Khaled Eye Specialist Hospital.
References
[ 1 ]C .P .A r r o y a v e ,I .U .S c o t t ,F .E .F a n t e s ,W .J .F e u e r ,a n dT .
G. Murray, “Corneal graft survival and intraocular pressure
control after penetrating keratoplasty and glaucoma drainage
device implantation,” Ophthalmology, vol. 108, no. 11, pp.
1978–1985, 2001.
[2] T. Casey and D. J. Mayer, “Glaucoma and corneal grafting,”
in Corneal Grafting: Principles and Practice, pp. 325–330, WB
Saunders, Philadelphia, Pa, USA, 1984.
[3] A. R. Irvine and H. E. Kaufman, “Intraocular pressure follow-
ing penetrating keratoplasty,” American Journal of Ophthal-
mology, vol. 68, no. 5, pp. 835–844, 1969.
[4] D.Paton,“Theprincipalproblemsofpenetratingkeratoplasty:
graft failure and graft astigmatism,” in Symposium on Medical
and Surgical Diseases of the Cornea, Transactions of the New
Orleans Academy of Ophthalmology, pp. 248–283, CV Mosby,
St. Louis, Mo, USA, 1980.
[ 5 ]R .A .T h o f t ,J .M .G o r d o n ,a n dC .H .D o h l m a n ,“ G l a u c o m a
following keratoplasty,” Transactions of the American Academy
of Ophthalmology and Otolaryngology,v o l .7 8 ,n o .2 ,p p .
OP352–OP364, 1974.
[6] E. T. Franc ¸ a ,E .S .A r c i e r i ,R .S .A r c i e r i ,a n dF .J .R o c h a ,“ A
study of glaucoma after penetrating keratoplasty,” Cornea, vol.
21, no. 3, pp. 284–288, 2002.
[7] O. Karadag, S. Kugu, G. Erdogan, B. Kandemir, S. Eraslan
Ozdil, and O. K. Dogan, “Incidence of and risk factors for
increased intraocular pressure after penetrating keratoplasty,”
Cornea, vol. 29, no. 3, pp. 278–282, 2010.
[8] M. Al-Mohaimeed, S. Al-Shahwan, A. Al-Torbak, and M. D.
Wagoner, “Escalation of glaucoma therapy after penetrating
keratoplasty,” Ophthalmology, vol. 114, no. 12, pp. 2281–2286,
2007.
[9] M. D. Wagoner, R. Ba-Abbad, M. Al-Mohaimeed, S. Al-
Swailem, and M. B. Zimmerman, “Postoperative complica-
tions after primary adult optical penetrating keratoplasty:
prevalence and impact on graft survival,” Cornea, vol. 28, no.
4, pp. 385–394, 2009.
[ 1 0 ]D .B .G o l d b e r g ,D .J .S c h a n z l i n ,a n dS .I .B r o w n ,“ I n c i d e n c e
of increased intraocular pressure after keratoplasty,” American
Journal of Ophthalmology, vol. 92, no. 3, pp. 372–377, 1981.
[11] C. M. Kirkness and L. A. Ficker, “Risk factors for the
development of postkeratoplasty glaucoma,” Cornea, vol. 11,
no. 5, pp. 427–432, 1992.
[12] F. M. Polack, “Glaucoma in keratoplasty,” Cornea, vol. 7, no. 1,
pp. 67–69, 1988.
[ 1 3 ]R .B .S i m m o n s ,R .A .S t e r n ,C .T e e k h a s a e n e e ,a n dK .R .
Kenyon, “Elevated intraocular pressure following penetrating
keratoplasty,” Transactions of the American Ophthalmological
Society, vol. 87, pp. 79–93, 1989.
[14] G. N. Foulks, “Glaucoma associated with penetrating kerato-
plasty,” Ophthalmology, vol. 94, no. 7, pp. 871–874, 1987.
[15] J. W. Karesh and V. S. Nirankari, “Factors associated with
glaucoma after penetrating keratoplasty,” American Journal of
Ophthalmology, vol. 96, no. 2, pp. 160–164, 1983.
[16] C. Redbrake and O. Arend, “Glaucoma following kerato-
plasty,” Ophthalmologe, vol. 97, no. 8, pp. 552–556, 2000.
[17] R. Sihota, N. Sharma, A. Panda, H. C. Aggarwal, and R.
Singh, “Post-penetrating keratoplasty glaucoma: risk fac-
tors, management and visual outcome,” Australian and New
Zealand Journal of Ophthalmology, vol. 26, no. 4, pp. 305–309,
1998.
[18] T. Dada, A. Aggarwal, K. Minudath et al., “Post-penetrating
keratoplasty glaucoma,” Indian Journal of Ophthalmology, vol.
56, no. 4, pp. 269–277, 2008.
[19] R. J. Olson and H. E. Kaufman, “A mathematical description
of causative factors and prevention of elevated intraocular
pressure after keratoplasty,” Investigative Ophthalmology and
Visual Science, vol. 16, no. 12, pp. 1085–1092, 1977.
[20] T. J. Zimmerman, T. Krupin, W. Grodzki, and S. R. Waltman,
“The eﬀect of suture depth on outﬂow facility in penetrating
keratoplasty,” Archives of Ophthalmology, vol. 96, no. 3, pp.
505–506, 1978.
[21] J. H. Lass and D. Pavan-Langston, “Timolol therapy in sec-
ondaryangle-closureglaucomapostpenetratingkeratoplasty,”
Ophthalmology, vol. 86, no. 1, pp. 51–59, 1979.
[22] E. J. Cohen, K. R. Kenyon, and C. H. Dohlman, “Iridoplasty
for prevention of post-keratoplasty angle closure and glau-
coma,” Ophthalmic Surgery, vol. 13, no. 12, pp. 994–996, 1982.
[23] C. M. Kirkness and C. Moshegov, “Post-keratoplasty glau-
coma,” Eye, vol. 2, no. 2, pp. S19–S26, 1988.
[24] B. Seitz, A. Langenbucher, N. X. Nguyen, M. K¨ uchle, and
G. O. H. Naumann, “Long-term follow-up of intraocular
pressure after penetrating keratoplasty for keratoconus and
Fuchs’dystrophy:comparisonofmechanicalandexcimerlaser
trephination,” Cornea, vol. 21, no. 4, pp. 368–373, 2002.
[25] A.L.Coleman,“Glaucoma,”TheLancet,vol.354,no.9192,pp.
1803–1810, 1999.
[26] R. S. Ayyala, “Penetrating keratoplasty and glaucoma,” Survey
of Ophthalmology, vol. 45, no. 2, pp. 91–105, 2000.
[27] S. Pramanik, D. C. Musch, J. E. Sutphin, and A. A. Farjo,
“Extendedlong-termoutcomesofpenetratingkeratoplastyfor
keratoconus,” Ophthalmology, vol. 113, no. 9, pp. 1633–1638,
2006.
[28] M. Erdurmus, E. J. Cohen, E. H. Yildiz et al., “Steroid-induced
intraocular pressure elevation or glaucoma after penetrating
keratoplasty in patients with keratoconus or Fuchs dystrophy,”
Cornea, vol. 28, no. 7, pp. 759–764, 2009.
[ 2 9 ]J .C .F a n ,K .C h o w ,D .V .P a t e l ,a n dC .N .J .M c G h e e ,“ C o r -
ticosteroid-induced intraocular pressure elevation in kera-
toconus is common following uncomplicated penetrating
keratoplasty,” Eye, vol. 23, no. 11, pp. 2056–2062, 2009.
[30] H. Al-Mezaine and M. D. Wagoner, “Repeat penetrating
keratoplasty: indications, graft survival, and visual outcome,”
British Journal of Ophthalmology, vol. 90, no. 3, pp. 324–327,
2006.
[31] F. McMillan and R. K. Forster, “Comparison of MacKay Marg,
Goldmann, and Perkins tonometers in abnormal corneas,”
Archives of Ophthalmology, vol. 93, no. 6, pp. 420–424, 1975.
[32] M. J. Doughty and M. L. Zaman, “Human corneal thickness
and its impact on intraocular pressure measures: a review and
meta-analysisapproach,”SurveyofOphthalmology,vol.44,no.
5, pp. 367–408, 2000.
[33] N. X. Nguyen, F. K. Horn, B. Seitz, C. Cursiefen, and M.
K¨ uchle, “Frequency-doubling perimetry in patients following
penetrating keratoplasty,” Cornea, vol. 23, no. 5, pp. 433–438,
2004.
[ 3 4 ]A .P .T a n n a ,A .W .R a d e m a k e r ,W .C .S t e w a r t ,a n dR .M .
Feldman, “Meta-analysis of the eﬃcacy and safety of α2-
adrenergic agonists, β-adrenergic antagonists, and topical
carbonic anhydrase inhibitors with prostaglandin analogs,”
Archives of Ophthalmology, vol. 128, no. 7, pp. 825–833, 2010.
[35] A. Konowal, J. C. Morrison, S. V. L. Brown et al., “Irreversible
corneal decompensation in patients treated with topical8 Journal of Ophthalmology
dorzolamide,” American Journal of Ophthalmology, vol. 127,
no. 4, pp. 403–406, 1999.
[36] R. S. Ayyala, D. A. Cruz, C. E. Margo et al., “Cystoid macular
edema associated with latanoprost in aphakic and pseudopha-
kic eyes,” American Journal of Ophthalmology, vol. 126, no. 4,
pp. 602–604, 1998.
[37] M. Wand, C. M. Gilbert, and T. J. Liesegang, “Latanoprost and
herpes simplex keratitis,” American Journal of Ophthalmology,
vol. 127, no. 5, pp. 602–604, 1999.
[38] H. D. Perry, E. D. Donnenfeld, A. J. Kanellopoulos, and G.
A. Grossman, “Topical cyclosporin A in the management of
postkeratoplasty glaucoma,” Cornea, vol. 16, no. 3, pp. 284–
288, 1997.
[39] G. L. Skuta, C. C. Beeson, E. J. Higginbotham et al., “Intraop-
erativemitomycinversuspostoperative5-ﬂuorouracilinhigh-
risk glaucoma ﬁltering surgery,” Ophthalmology, vol. 99, no. 3,
pp. 438–444, 1992.
[40] I. Chowers and U. Ticho, “Mitomycin-C in combined or
two-stage procedure trabeculectomy followed by penetrating
keratoplasty,” Journal of Glaucoma, vol. 8, no. 3, pp. 184–187,
1999.
[41] R. S. Ayyala, L. Pieroth, A. F. Vinals et al., “Comparison
of mitomycin C trabeculectomy, glaucoma drainage device
implantation, and laser neodymium: YAG cyclophotocoag-
ulation in the management of intractable glaucoma after
penetrating keratoplasty,” Ophthalmology, vol. 105, no. 8, pp.
1550–1556, 1998.
[42] A. Al-Torbak, “Graft survival and glaucoma outcome after
simultaneous penetrating keratoplasty and Ahmed glaucoma
valve implant,” Cornea, vol. 22, no. 3, pp. 194–197, 2003.
[ 4 3 ]P .A .S i d o t i ,A .Y .M o s n y ,D .C .R i t t e r b a n d ,a n dJ .A .S e e d o r ,
“Pars plana tube insertion of glaucoma drainage implants and
penetrating keratoplasty in patients with coexisting glaucoma
andcornealdisease,”Ophthalmology,vol.108,no.6,pp.1050–
1058, 2001.
[44] Y. H. Kwon, J. M. Taylor, S. Hong et al., “Long-term results
of eyes with penetrating keratoplasty and glaucoma drainage
tube implant,” Ophthalmology, vol. 108, no. 2, pp. 272–278,
2001.
[45] D. C. Y. Han, J. S. Mehta, Y. M. Por, H. M. Htoon, and D. T. H.
Tan, “Comparison of outcomes of lamellar keratoplasty and
penetrating keratoplasty in keratoconus,” American Journal of
Ophthalmology, vol. 148, no. 5, pp. 744–751, 2009.
[46] D. T. H. Tan, A. Anshu, A. Parthasarathy, and H. M. Htoon,
“Visual acuity outcomes after deep anterior lamellar kerato-
plasty: a case-control study,” British Journal of Ophthalmology,
vol. 94, no. 10, pp. 1295–1299, 2010.
[47] M. O. Price and F. W. Price, “Descemet’s stripping
with endothelial keratoplasty. Comparative outcomes with
microkeratome-dissected and manually dissected donor tis-
sue,” Ophthalmology, vol. 113, no. 11, pp. 1936–1942, 2006.
[48] I. Bahar, I. Kaiserman, W. Sansanayudh, E. Levinger, and D.
S. Rootman, “Busin guide vs forceps for the insertion of the
donor lenticule in Descemet stripping automated endothelial
keratoplasty,”AmericanJournalofOphthalmology,vol.147,no.
2, pp. 220–226, 2009.
[49] D. J. Covert and S. B. Koenig, “New triple procedure: de-
scemet’s stripping and automated endothelial keratoplasty
combined with phacoemulsiﬁcation and intraocular lens im-
plantation,” Ophthalmology, vol. 114, no. 7, pp. 1272–1277,
2007.
[50] S. B. Koenig and D. J. Covert, “Early results of small-incision
Descemet’sstrippingandautomatedendothelialkeratoplasty,”
Ophthalmology, vol. 114, no. 2, pp. 221–226, 2007.
[51] J. S. Lee, N. R. Desai, G. W. Schmidt et al., “Secondary angle
closure caused by air migrating behind the pupil in descemet
stripping endothelial keratoplasty,” Cornea,v o l .2 8 ,n o .6 ,p p .
652–656, 2009.
[ 5 2 ]W .B .L e e ,D .S .J a c o b s ,D .C .M u s c h ,S .C .K a u f m a n ,W .J .
Reinhart, and R. M. Shtein, “Descemet’s stripping endothelial
keratoplasty: safety and outcomes. a report by the American
Academy of Ophthalmology,” Ophthalmology, vol. 116, no. 9,
pp. 1818–1830, 2009.
[ 5 3 ]T .S .V a j a r a n a n t ,M .O .P r i c e ,F .W .P r i c e ,W .G a o ,J .T .
Wilensky, and D. P. Edward, “Visual acuity and intraocular
pressure after Descemet’s stripping endothelial keratoplasty in
eyes with and without preexisting glaucoma,” Ophthalmology,
vol. 116, no. 9, pp. 1644–1650, 2009.
[54] M. R. Banitt and V. Chopra, “Descemet’s stripping with
automated endothelial keratoplasty and glaucoma,” Current
Opinion in Ophthalmology, vol. 21, no. 2, pp. 144–149, 2010.
[ 5 5 ]T .S .V a j a r a n a n t ,M .O .P r i c e ,F .W .P r i c e ,J .T .W i l e n s k y ,a n d
D. P. Edward, “Intraocular pressure measurements following
Descemet stripping endothelial keratoplasty,” American Jour-
nal of Ophthalmology, vol. 145, no. 5, pp. 780–786, 2008.
[56] M. M. Whitacre and R. Stein, “Sources of error with use of
Goldmann-type tonometers,” Survey of Ophthalmology, vol.
38, no. 1, pp. 1–30, 1993.
[57] C. Kaufmann, L. M. Bachmann, and M. A. Thiel, “Compar-
ison of dynamic contour tonometry with Goldmann appla-
nation tonometry,” Investigative Ophthalmology and Visual
Science, vol. 45, no. 9, pp. 3118–3121, 2004.
[58] E. Schneider and F. Grehn, “Intraocular pressure meas-
urement—comparison of dynamic contour tonometry and
Goldmann applanation tonometry,” Journal of Glaucoma, vol.
15, no. 1, pp. 2–6, 2006.
[59] A. Kotecha, E. T. White, J. M. Shewry, and D. F. Garway-
Heath, “The relative eﬀects of corneal thickness and age
on Goldmann applanation tonometry and dynamic contour
tonometry,” British Journal of Ophthalmology, vol. 89, no. 12,
pp. 1572–1575, 2005.
[60] J. Y. F. Ku, H. V. Danesh-Meyer, J. P. Craig, G. D. Gamble, and
C. N. J. McGhee, “Comparison of intraocular pressure mea-
sured by Pascal dynamic contour tonometry and Goldmann
applanation tonometry,”Eye,vol.20,no.2,pp.191–198,2006.
[61] J. C. Bradley, E. G. Hernandez, I. R. Schwab, and M. J. Mannis,
“Boston type 1 keratoprosthesis: the University of California
Davis experience,” Cornea, vol. 28, no. 3, pp. 321–327, 2009.
[62] B. L. Zerbe, M. W. Belin, and J. B. Ciolino, “Results from the
multicenter Boston type 1 Keratoprosthesis study,” Ophthal-
mology, vol. 113, no. 10, pp. 1779–1784, 2006.
[63] P. A. Netland, H. Terada, and C. H. Dohlman, “Glaucoma
associatedwithkeratoprosthesis,”Ophthalmology,vol.105,no.
4, pp. 751–757, 1998.
[ 6 4 ]D .R i v i e r ,J .S .P a u l a ,E .K i m ,C .H .D o h l m a n ,a n dC .L .
Grosskreutz, “Glaucoma and keratoprosthesis surgery: role of
adjunctive cyclophotocoagulation,” Journal of Glaucoma, vol.
18, no. 4, pp. 321–324, 2009.
[65] M. Banitt, “Evaluation and management of glaucoma after
keratoprosthesis,” Current Opinion in Ophthalmology, vol. 22,
no. 2, pp. 133–136, 2011.
[66] C. H. Dohlman, C. L. Grosskreutz, T. C. Chen et al., “Shunts
to divert aqueous humor to distant epithelialized cavities after
keratoprosthesis surgery,” Journal of Glaucoma, vol. 19, no. 2,
pp. 111–115, 2010.
[67] E. K. Akpek, M. Harissi-Dagher, R. Petrarca et al., “Out-
comes of Boston Keratoprosthesis in aniridia: a retrospectiveJournal of Ophthalmology 9
multicenter study,” American Journal of Ophthalmology, vol.
144, no. 2, pp. 227–231, 2007.
[68] D. T. H. Tan, A. B. G. Tay, J. T. S. Theng et al., “Keratopros-
thesis surgery for end-stage corneal blindness in Asian eyes,”
Ophthalmology, vol. 115, no. 3, pp. 503–510, 2008.
[69] M. L. Conway, M. Wevill, A. Benavente-Perez, and S. L.
Hosking, “Ocular blood-ﬂow hemodynamics before and after
application of a laser in situ keratomileusis ring,” Journal of
Cataract and Refractive Surgery, vol. 36, no. 2, pp. 268–272,
2010.
[70] A. Ozdamar and O. Ocakoglu, “Optic nerve head blood ﬂow
using scanning laser Doppler ﬂowmetry after laser in situ
keratomileusis,”JournalofRefractiveSurgery,v ol.19,no .4,pp .
433–437, 2003.
[71] P. K. Agrawal, “The eﬀect of experimental ischaemia on the
retinal vessels in the rat,” Oriental Archives of Ophthalmology,
vol. 3, pp. 184–188, 1965.
[72] C. T. Dollery, P. Henkind, E. M. Kohner, and J. W. Paterson,
“Eﬀect of raised intraocular pressure on the retinal and
choroidal circulation,” Investigative Ophthalmology, vol. 7, no.
2, pp. 191–198, 1968.
[ 7 3 ]L .X u ,Y .W a n g ,S .W a n g ,Y .W a n g ,a n dJ .B .J o n a s ,“ H i g h
myopia and glaucoma susceptibility: the Beijing Eye Study,”
Ophthalmology, vol. 114, no. 2, pp. 216–220, 2007.
[74] E. S. Perkins and C. D. Phelps, “Open angle glaucoma, ocular
hypertension, low-tension glaucoma, and refraction,” Archives
of Ophthalmology, vol. 100, no. 9, pp. 1464–1467, 1982.
[75] S. M. Farrar, M. B. Shields, K. N. Miller, and C. M. Stoup,
“Risk factors for the development and severity of glaucoma
in the pigment dispersion syndrome,” American Journal of
Ophthalmology, vol. 108, no. 3, pp. 223–229, 1989.
[76] R. C. Tripathi, S. K. Parapuram, B. J. Tripathi, Y. Zhong, and
K. V. Chalam, “Corticosteroids and glaucoma risk,” Drugs and
Aging, vol. 15, no. 6, pp. 439–450, 1999.
[77] J. P. Kersey and D. C. Broadway, “Corticosteroid-induced
glaucoma: a review of the literature,” Eye,v o l .2 0 ,n o .4 ,p p .
407–416, 2006.
[ 7 8 ] H .J .G a r z o z i ,H .S .C h u n g,Y .L a n g,L .K a g e m a n n ,a n dA .H a r -
ris, “Intraocular pressure and photorefractive keratectomy: a
comparisonofthreediﬀerenttonometers,”Cornea,vol.20,no.
1, pp. 33–36, 2001.
[79] S. Shah, A. Chatterjee, M. Mathai et al., “Relationship between
corneal thickness and measured intraocular pressure in a
general ophthalmology clinic,” Ophthalmology, vol. 106, no.
11, pp. 2154–2160, 1999.
[80] R.C.W .W olfs,C.C.W .Kla v er ,J .R.V ingerling,D .E.Grobbee,
A. Hofman, and P. T. V. M. de Jong, “Distribution of central
cornealthicknessanditsassociationwithintraocularpressure:
theRotterdamstudy,”AmericanJournalofOphthalmology,vol.
123, no. 6, pp. 767–772, 1997.
[81] R. Vakili, S. A. Choudhri, S. Tauber, and M. B. Shields, “Eﬀect
of mild to moderate myopic correction by laser-assisted in
situ keratomileusis on intraocular pressure measurements
with Goldmann applanation tonometer, Tono-Pen, and pneu-
matonometer,” Journal of Glaucoma, vol. 11, no. 6, pp. 493–
496, 2002.
[82] C.E.West,J.A.Capella,andH.E.Kaufman,“Measurementof
intraocular pressure with a pneumatic applanation tonome-
ter,” American Journal of Ophthalmology, vol. 74, no. 3, pp.
505–509, 1972.
[83] S. Bayraktar and Z. Bayraktar, “Central corneal thickness and
intraocular pressure relationship in eyes with and with-
out previous LASIK: comparison of Goldmann applanation
tonometer with pneumatonometer,” European Journal of Oph-
thalmology, vol. 15, no. 1, pp. 81–88, 2005.
[84] O. E. Abbasoglu, R. W. Bowman, H. D. Cavanagh, and J. P.
McCulley, “Reliability of intraocular pressure measurements
after myopic excimer photorefractive keratectomy,” Ophthal-
mology, vol. 105, no. 12, pp. 2193–2196, 1998.
[85] A. Shrivastava, A. Madu, and J. Schultz, “Refractive surgery
andtheglaucomapatient,”CurrentOpinioninOphthalmology,
vol. 22, no. 4, pp. 215–221, 2011.
[86] G. D. Kymionis, M. A. Grentzelos, G. A. Kounis et al.,
“Intraocular pressure measurements after corneal collagen
crosslinking with riboﬂavin and ultraviolet A in eyes with
keratoconus,” Journal of Cataract and Refractive Surgery, vol.
36, no. 10, pp. 1724–1727, 2010.